內容目錄
China News, Guangzhou, March 6 (Cai Minjie, Zuo Jiaolei) Esophageal cancer is one of the most common malignant tumors in the digestive tract. A team of Chinese experts has recently completed a large prospective Phase III clinical study (JUPITER-06), creating a new regimen for the first-line treatment of advanced esophageal squamous cell carcinoma. The study showed that the new regimen extended progression-free survival and overall survival in patients with esophageal squamous cell carcinoma.
The above research was led by Professor Xu Ruihua and Chief Physician Wang Feng of Sun Yat-sen University Cancer Center, and was jointly completed by 72 units including Cancer Hospital of Chinese Academy of Medical Sciences, First Affiliated Hospital of Henan University of Science and Technology, and Cancer Hospital of Harbin Medical University. It has recently been published in the leading international oncology journal “CancerCell”.
Xu Ruihua said: “The JUPITER-06 study focuses on the high incidence of esophageal squamous cell carcinoma in China, and the application of domestically developed immunotherapy preparations is conducive to solving the treatment demand gap of Chinese patients. Limumab combined with TP chemotherapy will become a new standard for the first-line treatment of advanced esophageal squamous cell carcinoma.”
Esophageal squamous cell carcinoma and adenocarcinoma are the two main histological subtypes of esophageal cancer. Cancer predominates, accounting for more than 90%.
“Some people in our country have the habit of drinking strong tea, and also like to eat hot pot and other spicy hot food, which can easily damage the esophageal mucosal tissue; Excessive nitrite, these may be the incentives for esophageal cancer.” Xu Ruihua said that poor eating habits will repeatedly stimulate the esophageal mucosa, causing inflammation of the esophagus, and eventually induce tumors.
For a long time, for esophageal squamous cell carcinoma, platinum-based chemotherapy alone has been used for advanced patients.
In recent years, in addition to traditional regimens such as radiotherapy and chemotherapy, immune checkpoint inhibitors have become a new direction for the treatment of esophageal cancer due to their strong specificity, low side effects, and long tumor control time.
Toripalimab is the first domestically produced monoclonal antibody targeting PD-1 approved for marketing in my country. .
The clinical study (JUPITER-06) was launched in 2019 to investigate the efficacy and safety of toripalimab combined with paclitaxel and cisplatin in the first-line treatment of advanced esophageal squamous cell carcinoma. A total of 514 subjects were enrolled and randomized 1:1 to receive either toripalimab plus paclitaxel and cisplatin or placebo plus paclitaxel and cisplatin.
The results of the study showed that the combination of toripalimab and chemotherapy significantly prolonged progression-free survival and reduced the risk of disease progression or death by 42% compared with the placebo plus chemotherapy group (HR0.58 , P<0.0001), 27.8% of patients did not experience disease progression or death within 1 year (only 6.1% in the placebo group).
According to Wang Feng, “We observed an obvious ‘tail effect’ in the toripalimab group, indicating that the benefited patients could continue to obtain stable and long-term effects from immunotherapy, which Make esophageal cancer ‘chronic’ possible.” (End)
30 years of medical treatment, 3100 degree myopia patients I finally see what I look like
In February 2022, Clinical Cancer Research, a well-known international journal in the field of oncology, published the results of a phase I clinical study of the HER2 bispecific antibody KN026 in the treatment of HER2-positive metastatic breast cancer. Breast cancer is the most common cancer in women worldwide…
Diabetes reversal is not a dream! Endocrinologists launch 2 Type Diabetes Intensive Reverse Glucose Management Alliance
Text/Yangcheng Evening News All-Media Reporter Zhang Hua Correspondent Wu Zhenpeng Zhang Cancheng Photo/Hospital Provided Ms. Chen, 43, is from Dali, Yunnan, and has been working in Dongguan, Guangdong. Recently, Ms. Chen accidentally touched a small fleshy growth on her anus while taking a bath. “Although I have hemorrhoids for five or six years, I still feel uncomfortable when I go to the toilet…
73% of patients’ tumors shrink! New HER2 drug KN026 is expected to solve the problem of breast cancer drug resistance!
Text/Wang Shuhui, correspondent of Zhang Hua, an all-media reporter of Yangcheng Evening News, “During the Spring Festival, 4 cases of aortic dissection were received in February.” Zhong Zhimin, Director of Provincial Cardiovascular Surgery, Guangdong Second People’s Hospital Said, “This situation is a bit unexpected, and it may be related to the extremely cold weather during the Spring Festival this year. Fortunately, the timely operation, all…
Another Goddess Festival, enter “Healing Her Narrative Space” in the Cancer Hospital
Text/Yangcheng Evening News All-Media Reporter Chen Hui Correspondent Chen Jun “Hemerocallis blooms on the high green hills, pick one for my little girl, and pin it on the tip of your hair, Hold it in my heart…” In a warm melody of “Hemerocallis Flower”, patients and their families are arranging flowers, listening to the doctor’s small psychological relief class, and…
A small fat growth in the anus is not a hemorrhoid It’s a rectal tumor!
In February 2022, the journal Lung Cancer Translational Research published a study evaluating the combination of the PD-1 inhibitor nivolumab and recombinant human endostatin in previously treated patients with advanced non-small cell lung cancer. A study report on safety and efficacy in cell lung cancer (NSCLC). Immune checkpoint inhibitors (IC…
Long time to see you! Twenty years of rotten face can not be cured? It turns out that the root of the disease is in his own heart!
Text/Yangcheng Evening News All Media Reporter Chen Hui Intern Zheng Minshan Tu/Visual China’s slightly obese people want to try traditional Chinese medicine to lose weight, but they are afraid that it is too hard to drink soup and medicine, and they don’t have time to go to the hospital often for acupuncture to lose weight? Wang Shuxin, director of the Rehabilitation Center of the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, recommends two methods of losing weight in traditional Chinese medicine, which are suitable for no time…
Tear-like pain in the chest and back? Be alert for this Dangerous disease!
This is often seen in outpatient clinics. Some people’s blood vessels age faster than they age. This is “premature vascular aging.” People’s health and longevity are closely related to the health of the body’s blood vessels. Therefore, there has always been a saying that “vascular aging causes all kinds of diseases”. Many situations in life will accelerate the aging of blood vessels. Blood vessels…
National Ear Day Science: What You Must Know About Ears A few truths I know
Click to load the picture The medical staff is checking the children’s ears Photo by Han Suyuan China News Service, Hefei, March 2 (Fei Qinru Han Suyuan) March 3 is the 23rd National “Ear Love Day”. “The ear has two important functions, one is hearing, which is called deafness or hearing loss; the other is balance sense, balance…
Immune combined with anti-angiogenic drugs “combination punch” may break the drug resistance dilemma of lung cancer
Many people have probably heard that blood pressure lowering drugs cannot be taken with grapefruit. Many hypertensive patients are taboo for grapefruit. In fact, for hypertensive patients, it is not All people can’t eat grapefruit, because grapefruit contains furanocoumarin, which can inhibit…
National Committee of the Chinese People’s Political Consultative Conference Li Guodong: Strengthening primary medical and health services To relieve the pressure of the hospital
Everything is growing and the sun is shining, but you feel so tired? Seasonal depression is high, and experts teach you how to stay away from our reporter He Lina, trainee reporter Xu Ziying, correspondent Zhou Runtao, Wang Wenting, and Li Bin. On March 1, Hangzhou officially announced the arrival of spring. However, in this season of growth, in the psychiatric department of many hospitals in Hangzhou, due to depression,…
Want to lose weight but afraid of “hardship”? Chinese medicine therapy can help a>
China News Service, Shanghai, March 8 (Reporter Chen Jing) Among the many malignant tumors that seriously threaten women’s life and health, ovarian cancer is known as “the king of women’s cancer”. The reporter learned on the 8th that both patients with newly diagnosed ovarian cancer and patients with platinum-sensitive recurrence can benefit from targeted drugs-PARP inhibitors, which greatly…
40-year-old 60-year-old blood vessels? Doctor reminds: blood vessels should also prevent premature aging
Recently, the domestic new crown epidemic has shown the characteristics of many points, wide areas, and frequent occurrences. In view of the stronger transmission power, faster transmission speed and more concealed transmission process of the Omicron variant strain, the general public is requested to consciously abide by the epidemic prevention regulations in units, communities, public transportation, and public places. At the same time, do personal protection and wear your mouth properly…
When it’s cold in spring, you are more afraid of cold than others? Bowl of porridge
Text/Yangcheng Evening News All-Media Reporter Chen Hui Correspondent Liu Qingjun Tu/Visual China has been cold for several days, and the friends are all wrapped up in zongzi. Will you find that even if you wear a lot of clothes, your hands and feet are always cold, as if you are more afraid of cold than others. Professor Lan Senlin from the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine recommended a…
@all women, health concerns at every stage Anything?
Text/Photo by Yangcheng Evening News All-Media Reporter Zhang Hua Patients with early-stage lung cancer were treated with immunotherapy to remove all tumor cells. Do these patients still need surgery? This is an exciting and hesitant multiple-choice question for thoracic surgeons. On February 26, at the 10th Guangzhou Lung Cancer Forum, the Lung Cancer Research Institute of Sun Yat-Sen University…